Conflict of interest declaration: Peter AG Sandercock

Roles in: Stroke Group

1. In the past three years have you accepted the following from an organisation that may gain or lose financially from the publication of reviews by your review group in the Cochrane Database of Systematic Reviews (CDSR)?

a) Reimbursement for attending a conference or symposium (including travel, accommodation and/or hospitality)?
Yes - Travel expenses from Boehringer Ingelheim to lecture at South African Stroke Conference Travel expenses from Ever Pharma to lecture at Stroke Conference Nanjing

b) Fees for speaking?
Yes - Fee paid by Medtronic to report on the results of the CLOTS-3 trial of IPC at the Nordic stroke conference. Fee paid to my Department, not to me personally Fee from Ever Pharma to lecture at Stroke Conference Nanjing

c) Fees for organising education?
No

d) Funds for research?
No

e) Funds for a member of staff?
No

f) Fees for consulting?
Yes - Moleac for consulting on Neuroaid

g) Royalty payments?
No

2. In the past three years have you or your spouse/partner been employed by an organization that may in any way gain or lose financially from the publication of reviews by your review group in the CDSR?
No

3. Do you own stocks or shares in companies that may gain or lose financially from the publication of reviews by your review group in the CDSR?
No

4. Do you hold any patents for products that that may lead you to gain or lose financially from the publication of reviews by your review group in the CDSR?
No

5. Do you have any other competing interests (financial or non-financial)?
No